Elicio Therapeutics (ELTX) Price to Book (2023 - 2026)

Elicio Therapeutics (ELTX) has reported Price to Book for 4 consecutive years, with 10.79 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 84.24% year-over-year to 10.79; the trailing twelve-month figure through Jun 2026 stood at 10.79 (down 84.24% YoY), and the FY2025 full-year result was 86.61, up 1841.71% from the prior year.
• Price to Book climbed to 10.79 in Q2 2026 per ELTX's latest filing, from 138.66 in the prior quarter.
• Across five years, Price to Book topped out at 86.61 in Q4 2025 and bottomed at 138.66 in Q1 2026.
• Historically, Price to Book has averaged 5.98 across 4 years, with a median of 5.33 in 2023.
• The sharpest annual moves came in 2024 and 2025: Price to Book plunged 2140.95% in 2024, then soared 1841.71% in 2025.
• Over 4 years, Price to Book stood at 3.71 in 2023, then sank by 234.11% to 4.97 in 2024, then jumped by 1841.71% to 86.61 in 2025, then sank by 87.54% to 10.79 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 10.79, 138.66, and 86.61 for Q2 2026, Q1 2026, and Q4 2025 respectively.